Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311–21.

PubMed  Article  Google Scholar 

International Diabetes Federation. IDF diabetes atlas. 8th ed. Brussels: International Diabetes Federation; 2017.

Google Scholar 

Fagg J, Valabhji J. How do we identify people at high risk of type 2 diabetes and help prevent the condition from developing? Diabet Med. 2019;36(3):316–25.

CAS  PubMed  Article  Google Scholar 

Laakso M. Biomarkers for type 2 diabetes. Mol Metab. 2019;27S(Suppl):S139–46.

PubMed  Article  Google Scholar 

Jensen PN, Fretts AM, Yu C, et al. Circulating sphingolipids, fasting glucose, and impaired fasting glucose: the strong heart family study. EBioMedicine. 2019;41:44–9.

PubMed  Article  Google Scholar 

Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948–59.

CAS  PubMed  Article  Google Scholar 

Gray N, Picone G, Sloan F, et al. Relation between BMI and diabetes mellitus and its complications among US older adults. South Med J. 2015;108(1):29–36.

PubMed  PubMed Central  Article  Google Scholar 

Perkovic V, de Zeeuw D, Mahaffey KW, et al. Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS program randomised clinical trials. Lancet Diabetes Endocrinol. 2018;6(9):691–704.

CAS  PubMed  Article  Google Scholar 

Shi Z, Zhen S, Zimmet PZ, et al. Association of impaired fasting glucose, diabetes and dietary patterns with mortality: a 10-year follow-up cohort in Eastern China. Acta Diabetol. 2016;53(5):799–806.

CAS  PubMed  Article  Google Scholar 

Zhan Y, Sun H, Wang B, et al. Impaired fasting glucose predicts the development of hypertension over 6 years in female adults: results from the rural Chinese cohort study. J Diabetes Complications. 2017;31(7):1090–5.

Article  Google Scholar 

World Health Organization. Obesity and overweight. Available from: http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed in 23 Jul 2018.

Vieira JN, Braz MAD, Gomes FO, et al. Cardiovascular risk assessment using the lipid accumulation product index among primary healthcare users: a cross-sectional study. Sao Paulo Med J. 2019;137(2):126–31.

PubMed  Article  Google Scholar 

Tang ML, Zhong Y, Yue S, et al. Association between lipid accumulation product and diabetic retinopathy based on a community-based survey in Chinese with type 2 diabetes. Diabetes Metab Syndr Obes. 2019;12:513–8.

Article  Google Scholar 

Biyik Z, Guney I. Lipid accumulation product and visceral adiposity index: two new indices to predict metabolic syndrome in chronic kidney disease. Eur Rev Med Pharmacol Sci. 2019;23(5):2167–73.

CAS  PubMed  Google Scholar 

Jo A, Mainous AG 3rd. Information value of percent body fat with body mass index for the risk of abnormal blood glucose: a nationally representative cross-sectional study. BMJ Open. 2018;8(4):e019200.

PubMed  PubMed Central  Article  Google Scholar 

Schulze MB, Heidemann C, Schienkiewitz A, et al. Comparison of anthropometric characteristics in predicting the incidence of type 2 diabetes in the EPIC-Potsdam study. Diabetes Care. 2006;29(8):1921–3.

PubMed  Article  Google Scholar 

Ching YK, Chin YS, Appukutty M, et al. Comparisons of conventional and novel anthropometric obesity indices to predict metabolic syndrome among vegetarians in Malaysia. Sci Rep. 2010;10(1):20861.

Article  Google Scholar 

Tang ML, Zhou YQ, Song AQ, et al. The relationship between body mass index and incident diabetes mellitus in Chinese aged population: a cohort study. J Diabetes Res. 2021;2021:5581349.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ray L, Ravichandran K, Nanda SK. Comparison of lipid accumulation product index with body mass index and waist circumference as a predict of metabolic syndrome in Indian population. Metab Syndr Relat Disord. 2018;16(5):240–5.

PubMed  Article  Google Scholar 

Kahn HS. The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005;5:26.

PubMed  PubMed Central  Article  Google Scholar 

Nascimento-Ferreira MV, Rendo-Urteaga T, Vilanova-Campelo RC, et al. Reply-letter to the editor-the lipid accumulation product is a powerful tool to predict metabolic syndrome in undiagnosed Brazilian adults. Clin Nutr. 2017;36(3):907–8.

PubMed  Article  Google Scholar 

Zhu HT, Yu M, Hu H, et al. Factors associated with glycemic control in community-dwelling elderly individuals with type 2 diabetes mellitus in Zhejiang, China: a cross-sectional study. BMC Endocr Disord. 2019;19(1):57.

PubMed  PubMed Central  Article  Google Scholar 

Amini MR, Shahinfar H, Babaei N, et al. Association of dietary patterns with visceral adiposity, lipid accumulation product, and triglyceride-glucose index in Iranian adults. Clin Nutr Res. 2020;9(2):145–56.

PubMed  PubMed Central  Article  Google Scholar 

Lee JW, Lim NK, Park HY. The product of fasting plasma glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged Koreans. BMC Endocr Disord. 2018;18(1):33.

PubMed  PubMed Central  Article  Google Scholar 

Lee JW, Lim NK, Park HY. The product of fasting glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged Koreans. BMC Endocr Disord. 2018;18(1):33.

PubMed  PubMed Central  Article  Google Scholar 

de Oliveira CC, Roriz AKC, Ramos LB, et al. Indicators of adiposity predictors of metabolic syndrome in the elderly. Ann Nutr Metab. 2017;70(1):9–15.

PubMed  Article  Google Scholar 

Koo BK, Kim SW, Yi KH, et al. Changing relative contribution of abdominal obesity and a family history of diabetes on prevalence of diabetes mellitus in Korean men and women aged 30–49 years from 2001 to 2010. J Diabetes. 2015;7(4):465–72.

PubMed  Article  Google Scholar 

Choi J, Choi JY, Lee SA, et al. Association between family history of diabetes and clusters of adherence to healthy behaviors: cross-sectional results from the Health Examinees-Gem (HEXA-G) study. BMJ Open. 2019;9(6):e025477.

PubMed  PubMed Central  Article  Google Scholar 

Imes CC, Lewis FM. Family history of cardiovascular disease, perceived cardiovascular disease risk, and health-related behavior: a review of the literature. J Cardiovasc Nurs. 2014;29(2):108–29.

PubMed  PubMed Central  Article  Google Scholar 

Acheson LS, Wang C, Zyzanski SJ, et al. Family history and perceptions about risk and prevention for chronic diseases in primary care: a report from the family healthware impact trial. Genet Med. 2010;12(4):212–8.

PubMed  PubMed Central  Article  Google Scholar 

Tian T, Pei H, Chen Z, et al. Comparison of lipid accumulation product and body mass index as indicators of diabetes diagnosis among 215,651 Chinese adults. Peer J. 2020;8:e8483.

PubMed  PubMed Central  Article  Google Scholar 

Holtrop J, Spiering W, Nathoe HM, et al. Apparent therapy-resistant hypertension as risk factor for the development of type 2 diabetes mellitus. J Hypertens. 2020;38(1):45–51.

CAS  PubMed  Article  Google Scholar 

Andersson T, Alfredsson L, Källberg H, et al. Calculating measures of biological interaction. Eur J Epidemiol. 2005;20(7):575–9.

PubMed  Article  Google Scholar 

Chen C, Lu FC, Department of Disease Control Ministry of Health, PR China. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;Suppl:1–36.

Google Scholar 

Zhai Y, Zhao W, Chen C. Verification on the cut-offs of waist circumference for defining central obesity in Chinese elderly and tall adults. Zhonghua Liu Xing Bing Xue Za Zhi. 2010;31(6):621–5 (Article in Chinese).

PubMed  Google Scholar 

Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Rev. 2010;23(2):247–69.

PubMed  Article  Google Scholar 

Liu L, Writing Group of 2010 Chinese Guidelines for the Management of Hypertension. 2010 Chinese guidelines for the management of hypertension. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39(7):579–615 (Article in Chinese).

PubMed  Google Scholar 

Lian F, Ni Q, Shen Y, et al. International traditional Chinese medicine guideline for diagnostic and treatment principles of diabetes. Ann Palliat Med. 2020;9(4):2237–50.

PubMed  Article  Google Scholar 

Joint Committee for Chinese Adult Dyslipidemia Prevention and Guidelines Formulation. Dyslipidemia prevention and guidelines for Chinese Adults. Chin J Cardiol. 2007;35(5):390–419.

Google Scholar 

Knol MJ, VanderWeele TJ, Groenwold RHH, et al. Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol. 2011;26(6):433–8.

PubMed  PubMed Central  Article  Google Scholar 

Zhang F, Wan Q, Cao H, et al. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China. BMJ Open. 2018;8(5):e019735.

PubMed  PubMed Central  Article  Google Scholar 

Zhang X, Meng X, Wang Y, et al. Six-year follow-up study on the association between white blood cell count and fasting blood glucose level in Chinese adults: a community-based health examination survey. Diabetes Metab Res Rev. 2019;35(4):e3125.

Article